North America Genetic Testing Market to 2032
Overview
The North America Genetic Testing Market is expected to reach a 38.21 USD Billion by 2032 and is projected to grow at a CAGR of 23.83% from 2025 to 2032.
Revenue, 2024 (USD Billion)
11.23
Forecast, 2032 (USD Billion)
38.21
CAGR, 2024 - 2032
23.83%
Report Coverage
North America
North America Genetic Testing Market 2018-2032 USD Billion
North America Genetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 11.23 USD Billion
- Projected Market Size (2032): 38.21 USD Billion
- CAGR (2025-2032): 23.83%
Key Findings of North America Genetic Testing Market
- The North America Genetic Testing Market was valued at 11.23 USD Billion in 2024.
- The North America Genetic Testing Market is likely to grow at a CAGR of 23.83% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cancer in Diseases Segment accounted for the largest share of the market with a revenue of 4.72 USD Billion
- The fastest growing segment Diagnostic Testing in Type Segment grew Fastest with a CAGR of 27.15% during the forecast period from 2024 to 2032.
North America Genetic Testing Market Scope
North America Genetic Testing Market Segmentation & Scope
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Diagnostic Testing
- Prenatal Testing
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
North America Genetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 11.23 USD Billion |
| Market Value in 2032 | 38.21 USD Billion |
| CAGR (2025-2032) | 23.83% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Diseases,Technology,End User |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 11.23 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 8,755.11 USD Million in 2024.
Segments and Scope
-
North America Genetic Testing Market to 2032, By Type
- Prenatal Testing is the largest segment in North America Genetic Testing Market to 2032 with a revenue of 4.37 USD Billion in the year 2024.
- Diagnostic Testing is the Fastest growing segment in North America Genetic Testing Market to 2032 with a Growth rate of 24.75 % in forecast period 2025-2032.
-
North America Genetic Testing Market to 2032, By Diseases
- Cancer is the largest segment in North America Genetic Testing Market to 2032 with a revenue of 4.72 USD Billion in the year 2024.
- Cancer is the Fastest growing segment in North America Genetic Testing Market to 2032 with a Growth rate of 25.40 % in forecast period 2025-2032.
-
North America Genetic Testing Market to 2032, By Technology
- Polymerase Chain Reaction is the largest segment in North America Genetic Testing Market to 2032 with a revenue of 3.30 USD Billion in the year 2024.
- Polymerase Chain Reaction is the Fastest growing segment in North America Genetic Testing Market to 2032 with a Growth rate of 26.54 % in forecast period 2025-2032.
-
North America Genetic Testing Market to 2032, By End User
- Hospitals is the largest segment in North America Genetic Testing Market to 2032 with a revenue of 3.06 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Genetic Testing Market to 2032 with a Growth rate of 26.62 % in forecast period 2025-2032.
North America Genetic Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Cepheid | |||
| Fulgent Genetics | |||
North America Genetic Testing Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Genetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Genetic Testing Market is segmented based on Segmentation Type,Diseases,Technology,End User.
North America Genetic Testing Market was valued at USD 11.23(Revenue in USD Billion) in 2021.
North America Genetic Testing Market is projected to grow at a CAGR of 23.83% during the forecast period of 2024 to 2032.
The Cancer segment is expected to dominate the North America Genetic Testing Market, holding a largest market share of 4.72 USD Billion in 2024
North America Genetic Testing Market Scope
North America Genetic Testing Market Segmentation & Scope
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Diagnostic Testing
- Prenatal Testing
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
Frequently Asked Questions
The North America Genetic Testing Market is segmented based on Segmentation Type,Diseases,Technology,End User.
North America Genetic Testing Market was valued at USD 11.23(Revenue in USD Billion) in 2021.
North America Genetic Testing Market is projected to grow at a CAGR of 23.83% during the forecast period of 2024 to 2032.
The estimated market value of the North America Genetic Testing Market for final year is USD 38.21 (USD Billion).
North America Genetic Testing Market Company Profiling
Frequently Asked Questions
The North America Genetic Testing Market is segmented based on Segmentation Type,Diseases,Technology,End User.
North America Genetic Testing Market was valued at USD 11.23(Revenue in USD Billion) in 2021.
North America Genetic Testing Market is projected to grow at a CAGR of 23.83% during the forecast period of 2024 to 2032.
The estimated market value of the North America Genetic Testing Market for final year is USD 38.21 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.